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Abstract 
Objectives: Epidemiological data on musculoskeletal conditions such as degenerative joint diseases 
and bone fractures are lacking in low- and middle-income countries. This survey aimed to estimate 
the prevalence and causes of musculoskeletal impairment in Fundong Health District, North-West 
Cameroon.   
Methods: Fifty-one clusters of 80 people (all ages) were selected using probability proportionate to 
size sampling. Households within clusters were selected by compact segment sampling. Six screening 
questions were asked to identify participants likely to have a musculoskeletal impairment (MSI). Par-
ticipants screening positive to any screening question underwent a standardized examination by a 
physiotherapist to assess presence, cause, diagnosis and severity of impairment. 
Results: In total, 3,567 of 4,080 individuals enumerated for the survey were screened (87%). The all-
age prevalence of MSI was 11.6% (95% CI: 10.1-13.3). Prevalence increased with age, from 2.9% in 
children to 41.2% in adults 50 years and above. The majority of MSI cases (70.4%) were classified as 
mild, 27.2% as moderate and 2.4% as severe. Acquired non-trauma comprised 67% of the diagnoses. 
The remainder included trauma (14%), neurological (11%), infection (5%) and congenital (3%). The 
most common individual diagnosis was degenerative joint disease (43%). Over one third (38%) of in-
dividuals with MSI had never received medical care or rehabilitation for their condition.  
Conclusions: This survey contributes to the epidemiological data on MSI in low- and middle-income 
countries. Nearly half of adults aged over 50 years had an MSI. There is a need to address the treat-
ment and rehabilitative service gap for people with MSI in Cameroon.  
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Introduction 
Musculoskeletal disorders are one of the leading contributors to loss in healthy life expectancy (1) 
and include conditions that can affect muscles, bones and joints, such as degenerative joint diseases 
and bone fractures. People with disabilities, of which physical disability is one of the most common 
forms (2), frequently experience exclusion from education and employment opportunities (3) and 
barriers to accessing health and rehabilitation services (4) and are at greater risk of poverty (3).  
The Bone and Joint Decade (2000 – 2010) (5), endorsed by the United Nations and WHO, 
was established to raise awareness about the impact that musculoskeletal conditions have on com-
munities. Despite this, there is lack of data on prevalence and causes of MSI in low and middle in-
come countries (LMIC) (6). This reflects, in part, the complexities of MSI and lack of agreement in 
case definition and survey methodology (2). Estimates of disability in LMIC have often relied on self-
report of disability asked as a single question, which is likely to lead to underestimates (7) or report-
ed functional limitations (8) which may not capture all MSI. Surveys using objective standardized 
screening criteria to generate reliable and comparable estimates of prevalence, cause and severity 
of MSI are lacking (9). These data are needed to understand and address the health and rehabilita-
tion service needs of persons with MSI. 
To address this gap, the Rapid Assessment of MSI (RAM) was developed as an all-age popu-
lation based survey method to estimate the prevalence and causes of MSI, providing data to help 
plan and advocate for medical, rehabilitation and other services (9). A survey using this method es-
timated the prevalence of MSI as 5.2% in Rwanda (10). These data are needed in other LMIC settings 
to provide locally relevant data for planning services and to build the global evidence base with re-
gards to the epidemiology of MSI.  
The aim of this study is to estimate the prevalence and causes of musculoskeletal impair-
ments in Fundong Health District, North West Cameroon.   
 
Methods 
Sampling 
The population-based survey included people of all ages. Data were collected from August to Octo-
ber 2013 in Fundong Health District, North West Cameroon. The expected prevalence of MSI was es-
timated to be 4% (6, 10). This required a sample of 4,056 individuals and assumed a precision of 
20%, 95% confidence, a design effect of 1.5 and 20% non-response.  
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A two-stage sampling procedure was used. Fifty-one clusters of 80 people were selected us-
ing probability proportionate to size sampling. The 2005 census data were used as the sampling 
frame. Compact segment sampling was used to select households within clusters. Maps showing the 
approximate distribution of the population were divided into segments of 80 people and one seg-
ment was randomly selected. The enumerators visited all houses door-to-door in that segment until 
80 people were included.  
At the household, the name, age, sex and contact details of each household member was 
recorded. Household members were informed about the survey and invited to attend a previously 
identified central location over the next two days. If an eligible person did not attend the central lo-
cation the enumerators visited their household at least twice to encourage attendance. If they were 
unable to travel to the central location (e.g. due to mobility impairment) the survey team visited 
them at their house at the end of the second day. 
 
Screening for musculoskeletal impairment 
We used the RAM method for this study (9). Six initial screening questions were used to assess a) dif-
ficulty using the musculoskeletal system, b) use of mobility aids, and c) whether the participant con-
sidered any of their body parts to be misshapen. This screening tool has been shown to have high 
sensitivity (99%) and specificity (97%) (9). A physiotherapist examined participants with a positive 
response to any screening question. The examination included standardised observation of activities 
(e.g. walking and picking up small items) to assess functioning. The physiotherapist also examined 
the affected area of the body. The diagnoses were categorised as congenital, traumatic, infective, 
neurological, or acquired non-traumatic non-infective. Up to two diagnoses were permissible per 
identified case of MSI. Aetiology was recorded where it was known by asking the participants about 
when and how the impairment developed. Based on these examinations, the participant was cate-
gorised as having either mild, moderate or severe musculoskeletal impairment.  Participants were 
also asked about treatment or rehabilitation that they had received for their impairment and the 
physiotherapists made referral recommendations, with consideration to available services in Came-
roon. 
 
Self-reported functional difficulty 
In addition to clinical screening, participants were screened for self-reported functional limitations 
using the Washington Group (WG) extended set (adult or child version) (11, 12). The primary care-
giver was interviewed as a proxy for children under eight years. The domain on mobility for children 
asks: “Compared with children of the same age, does [name] have difficulty walking?”; and for 
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adults: “Do you have difficulty walking or climbing steps?” These questions are assessed using a four-
point response scale (“no difficulty”, “some difficulty”, “a lot of difficulty” or “cannot do at all”). We 
compared these responses with clinically measured MSI. 
 
Training 
Three survey teams received 10 days training. The inter-observer variation for the measurement of 
MSI level and diagnosis of cause was assessed to ensure an acceptable standard (i.e. Kappa ≥0.6). 
The questionnaires were cognitively tested and checked for context relevance, and the survey pro-
tocol was pilot tested for suitability. 
 
Data analysis 
Data were analysed using STATA 14.0 (StataCorp LP, College Station, Texas). The confidence around 
the prevalence estimates accounted for the cluster sampling design. Sensitivity, specificity and posi-
tive and negative predictive values were estimated in the comparison of clinical measures to self-
reported mobility difficulties.  
Ethics 
Ethical Approval for the study was granted by the National Ethics Committee for Research in Human 
Health (Cameroon), the Cameroon Baptist Convention Health Board Institutional Review Board and 
the London School of Hygiene & Tropical Medicine. 
 Informed written/finger print consent was obtained from all participants. For children <21 
years, a caregiver was required to provide written/finger print consent and to remain present 
throughout the screening as per national requirements. 
Referral services available in the region were mapped pre-emptively to ensure appropriate on-
ward referral for any individuals identified with unmet healthcare needs. All people identified as 
having an impairment in the study, regardless of health or other need, were referred to a Communi-
ty-based Rehabilitation (CBR) or Self Help Group program for additional support. Clinical team mem-
bers distributed basic medicines where appropriate. 
 
Results 
A total of 4,080 individuals (51 clusters of 80 people) were enumerated for the population-based 
survey, of whom 3,567 were screened (response rate 87.4%). Among non-responders 0.5% (n=17) 
refused and 12.7% (n=521) were unavailable. Mean age was higher amongst non-responders (39.4 
years 95% CI: 26.1 - 52.8 amongst refusers, 28.1 years 95% CI: 26.4 - 29.7 amongst those who were 
unavailable) compared to people who were examined (24.4 years 95% CI: 23.6 - 25.1). The propor-
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tion of male and female participants was similar across those examined and those unavailable, but 
refusers were more likely to be female (those examined 59% female, unavailable 56% female and re-
fused 65% female). 
The age distribution of the study population was similar to that of the national population ac-
cording to the census data but females were over represented in the sample (Table 1). Of the 3,567 
individuals screened, 415 cases of MSI were identified giving an all-age MSI prevalence of 11.6% 
(95% CI: 10.1 – 13.3) (Table 2). The prevalence of MSI increased with age from 2.9% (95%CI: 1.9 – 
4.3) among children aged 0-17 years to 41.2% (95%CI: 36.1 – 46.4) in individuals aged 50 years or 
higher (Table 2). The prevalence of MSI in women was higher 12.9% (95%CI: 11.2 – 14.9) than men 
9.8% (95%CI: 8.0 – 11.8) but this difference was not statistically significant. The majority of MSI cases 
(70.4%) were classified as mild, 27.2% as moderate and 2.4% as severe. 
Extrapolating these findings to the population of Cameroon, we estimate there are a total of 
35,000 people per million population with a moderate or severe MSI and 116,000 people per million 
population with any MSI in this setting. By age there are an estimated; 15,950 children with MSI 
aged 0-17 years (95% CI: 10,450 – 23, 650), 34,920 aged 18-50 years (95%CI: 27,000 – 44, 640) and 
37,080 adults > 50 years (95%CI: 32,490 – 41,760).  
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Table 1. Age and gender distribution of district (census) and study sample population 
 Males Females Total 
Age group District* Study sample District Study sample District Study sample 
0-9 285,644 (31.4%) 609 (42%) 279,340 (28.2%) 630 (30%) 564,984 (29.7%) 1,239 (35%) 
10-19 258,047 (28.4%) 399 (27%) 257,261 (26.0%) 423 (20%) 515,308 (27.1%) 822 (23%) 
20-29 136,854 (15.0%) 77 (5%) 174,712 (17.6%) 307 (15%) 311,566 (16.4%) 384 (11%) 
30-39 83,977 (9.2%) 70 (5%) 107,390 (10.8%) 197 (9%) 191,367 (10.1%) 267 (7%) 
40-49 55,672 (6.1%) 67 (5%) 70,492 (7.1%) 152 (7%) 126,164 (6.6%) 219 (6%) 
50-59 38,749 (4.3%) 61 (4%) 47,397 (4.8%) 146 (7%) 86,146 (4.5%) 207 (6%) 
60-69 28,845 (3.2%) 60 (4%) 32,158 (3.2%) 127 (6%) 61,003 (3.2%) 187 (5%) 
70-79 15,709 (1.7%) 66 (5%) 14,930 (1.5%) 86 (4%) 30,639 (1.6%) 152 (4%) 
80+ 6,436 (0.7%) 46 (3%) 6,934 (0.7%) 44 (2%) 13,370 (0.7%) 90 (3%) 
Total 909,933 (47.9%) 1,455 (40.8) 990,614 (52.1%) 2,122 (59.2%) 1,900,547 (100%) 3,567 
NB: * Cameroon Census 2005 demographic projection for North West Region 2014 
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Table 2. Prevalence of musculoskeletal impairments by age, gender and impairment severity 
 
 
 
 
 Total 0-17 years 18-49 years 50+ years Male Female 
 N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) 
Any MSI 415 11.6 (10.1 – 13.3) 58 2.9 (1.9-4.3) 95 9.7 (7.5 – 12.4) 262 41.2 (36.1 – 46.4) 142 9.8 (8.0 – 11.8) 273 12.9 (11.2 – 14.9) 
Mild 292 8.2 (6.8 – 9.8) 32 1.6 (1.1 – 2.5) 67 6.8 (5.1 – 9.2) 193 30.3 (25.3 – 35.9) 100 6.9 (5.2 – 9.0) 192 9.1 (7.6 – 10.9) 
Moderate 113 3.2 (2.5-4.0) 24 1.2 (0.7-2.1) 24 2.4 (1.6-3.8) 65 10.2 (7.8-13.3) 39 2.7 (1.9-3.8) 74 3.5 (2.7-4.6) 
Severe 10 0.3 (0.2-0.5) 2 0.1 (0.03-0.4) 4 0.4 (0.2-1.1) 4 0.6 (0.2-1.7) 3 0.2 (0.07-0.6) 7 0.3 (0.2-0.7) 
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Age at impairment 
Among all individuals with MSI, just over two-thirds of the impairment (68%) was aquired above the 
age of 50 years, with 6% present at birth. Among the children with MSI, 30% were born with their 
condition and  28% aquired the impairment before they were 5 years. Among adults aged 18-50 
years with MSI, just under half (47%) aquired their impairment during their adult years (i.e. 
>17years). Among adults aged >50 years with MSI, the vast majority (96%) had developed their im-
pairment above the age of 40 years. 
Diagnoses 
The causes of MSI are shown in Table 3. There were a total of 455 diagnoses for the 415 participants 
with MSI. Overall, 67% of all MSI diagnoses were acquired non-traumatic non-infective causes, 14% 
were due to trauma, 11% had neurological causes, 5% were due to infection and 3% were congeni-
tal. Extrapolating these estimates to the total population of Cameroon suggests there are approxi-
mately 1,736,000 MSI diagnoses in the country. Prevalence and MSI diagnoses varied by age (Figure 
1). Among the children aged 0-17 years, neurological, trauma and infective diagnoses were the most 
common. With increasing age there was a proportional increase in MSI due to acquired non-
traumatic causes so that 83% of the diagnoses for older adults (aged >50 years) were in this catego-
ry. Among the 415 people with a MSI, 8% had a vision impairment, 15% had a hearing impairment 
and 2% had epilepsy. Overall 21% of people with a MSI also had at least a vision or hearing impair-
ment or epilepsy. 
Aetiology 
Aetiology was unknown for the majority (59%) of the individuals with MSI. Fifteen percent of MSI 
was due to trauma, 8% was congenital (without family history) and 6% was due to infection. Other 
aetiologies that include iatrogenic (1%), neoplasm (1%), family history (2%), developmental (1%) and 
perinatal hypoxia (0.3%) were relatively rare. 
Previous Treatment 
Participants were asked about previous interventions that they had received relating to their im-
pairment. Previous interventions that were commonly reported were medication (49%) followed by 
traditional medicine (18%), mobility aids (11%) and physiotherapy (7%). Over one third of individuals 
with MSI (38%) reported they had never received any medical or rehabilitation services.  
Recommended Treatment 
At least one medical or rehabilitation services was recommended for 74% of individuals with MSI by 
the clinician during the survey. Medication (66%) and physiotherapy (65%) were the most commonly 
recommended treatments, followed by mobility aids (30%), surgery (9%) and long-term care (e.g. in 
a hospital) (9%).   
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Table 3. Cause of MSI in survey, and extrapolated to population of Cameroon  
Diagnosis Number  Total in cate-
gory (%) 
Extrapolated total number of 
diagnostic category to nearest 
1,000 (95%CI) 
Total Congenital  14 3% 52,000 (42,000-65,000) 
Polydactyly 2    
Congenital absence of all/part of tibia 1    
Clubfoot 2    
Other congenital abnormality of lower limb 6    
Congenital deformity of thoracolumbar spine 1    
Multiple congenital abnormalities 2    
Total Infective  21 5% 87,000 (69,000-108,000) 
Joint infection 5    
Bone infection 3    
Skin/soft tissue infection/wound 13    
Total trauma   65  14% 278,000 (221,000-346,000) 
Burn contracture 7    
Fracture malunion 11    
Spinal injury 1    
Recurrent/chronic dislocation 1    
Post traumatic joint stiffness 3    
Tendon Problem 6    
Muscle problem 4    
Peripheral nerve problem 4    
Amputation 10    
Other trauma 18    
Total neurological  51  11% 208,000 (166,000 -260,000) 
Epilepsy 11    
Developmental delay 6    
Cerebral palsy 8    
Paraplegia 1    
Hemiplegia 5    
Peripheral nerve palsy/facial weakness 8    
Polio 1    
Other neurological 11    
Total Acquired non-traumatic  304 67% 750,000 (358,000-845,000) 
Degenerative joint diseases 196    
Non-infective non traumatic joint disease 4    
Knock knees 5    
Other joint deformity 3    
Bone/skin/soft tissue tumour 7    
Scoliosis 1    
Spinal pain limiting spine function 41    
TB/spine infection 1    
Limb pain  8    
Lymphoedema 2    
Other acquired non-traumatic  36    
Total  455  
1,736,000 (1,383,000-
2,169,000) 
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Figure 1. Diagnostic categories of MSI, by age group 
 
Table 4. Recommended intervention for individuals with MSI 
 
Intervention previously receivedab Intervention recommendedac 
 
N  % N % 
None 148 38% 98 26% 
Medication 192 49% 246 66% 
Plaster/Splintage 10 3% 16 4% 
Physiotherapy 26 7% 244 65% 
Special Seating 0 0% 3 1% 
Mobility aid 45 11% 114 30% 
General assistive aid 9 2% 11 3% 
Orthosis/prosthesis 0 0% 6 2% 
Wheelchair 2 1% 4 1% 
Surgery 11 3% 33 9% 
Long-term care (e.g. 
hospital/institution) 14 4% 33 9% 
Traditional medicine 69 18% 0 0% 
Other: 9 2% 23 6% 
a More than one intervention could be recommended for each person, hence totals equal more than 
100% 
b data were missing for 42 individuals and they were excluded from analysis.  
c Data were missing from 23 individuals and they were excluded from analysis 
0.0% 
5.0% 
10.0% 
15.0% 
20.0% 
25.0% 
30.0% 
35.0% 
40.0% 
45.0% 
50.0% 
0-17 18-50 >50 All Ages 
P
re
va
le
n
ce
 p
e
rc
e
n
t 
Age group 
Total Congenital Total Infective Total trauma  Total neurological Total acquired non traumatic 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Comparison of clinically measured and self-reported difficulties with mobility 
Of the 406 participants with clinically assessed MSI (mild, moderate or severe) and Washington 
Group responses in the domain of “walking/climbing”, 286 reported ‘some’ or ‘more’ problem with 
mobility (sensitivity = 70%) using the Washington Group (WG) questionnaire. Of the 2,902 people 
who did not have an MSI according to the clinical assessment, 2,346 reported no difficulty with mo-
bility (specificity: 81%). Of the 2,465 who reported no difficulty, 2,346 also had no MSI (negative 
predictive value: 95%). Among the 841 who reported ‘some’ or ‘more’ difficulty, 286 had a clinically 
assessed MSI (positive predictive value: 34%). If a narrower self-reported definition of ‘a lot of diffi-
culty’ or greater is used, the sensitivity decreased to 18%, specificity increased to 99%, and positive 
and negative predictive values were 72% and 90% respectively. 
 
Table 5 Relationship between clinically assessed impairment and self-reported difficulties with mo-
bility 
 Self-reported difficulties 
Clinically assessed MSI None N (%) Some N (%) A lot N (%) Extreme/ Cannot do 
N (%) 
No MSI (n=2902) 2,346 (81%) 526 (18%) 29 (1%) 0 
Mild (n=287) 90 (32%) 172 (60%) 25 (9%) 0 
Moderate (n=110) 27 (25%) 41 (37%) 40 (36%) 2 (2%) 
Severe  (n=8) 2 (25%) 0 4 (50%) 2 (25%) 
Any MSI* (n=405) 2,465 (75%) 739 (22%) 98 (3%) 4 (0.1%) 
*NB: WG data were missing for 30 people  
 
Summary of results 
This all age population-based survey conducted in Fundong district in North-West Cameroon esti-
mated an MSI prevalence of 11.6% (95% CI 10.1 – 13.3). The majority of MSI cases (70.4%) were 
classified as mild, 27.2% as moderate and 2.4% as severe. The prevalence of MSI increased dramati-
cally with age, with 41.2% of cases of MSI found in people >50 years. Overall, 67% of MSI were due 
to acquired non-traumatic non-infective causes. The remainder of causes included trauma (14%), 
neurological (11%), infection (5%) and congenital (3%). Among participants ≥50 years, the cause of 
MSI was largely attributed to a broadly defined condition called degenerative joint disease (e.g. os-
teoarthritis).  
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Discussion 
The data from this survey provide useful information to assist planning of rehabilitation and other 
services for persons with MSI in Cameroon. For example, this study estimates that there are approx-
imately of 35,000 people per million population in Cameroon with a moderate or severe MSI and 
116,000 with any MSI. Throughout the country, approximately 800,000 people will have mild or 
worse degenerative joint conditions. The need for equipment (e.g. assistive devices) can also be es-
timated from this information and production and supply can be anticipated accordingly. Potential 
requirements for services such as rehabilitation and surgery can be similarly estimated. If these re-
sults are combined with a situational analysis of existing capacity and resources, as well as availabil-
ity and affordability of services, this can inform advocacy and planning of future rehabilitation and 
service provision. For example, the information collected in this survey on recommended interven-
tions suggest that approximately 1,130,000 people in Cameroon could benefit from physiotherapy 
and 156,000 from surgery, yet there are currently 130 physiotherapists and physiotherapy assistants 
and 45 orthopaedic surgeons estimated in the country(13). 
The overall prevalence of MSI in this study is double the 5.2% (95% CI 4.5–5.9) reported in 
Rwanda which used similar survey methods. While the estimated prevalence of moderate MSI 
(Cameroon 3.2%, Rwanda 2.4%) and severe (Cameroon 0.3%, Rwanda 0.4%), the number of partici-
pants assessed as having mild MSI was considerably higher in Cameroon (8.2% vs 2.4%). The reasons 
for this are unclear, but may, in part, reflect the higher proportion of older adults (>50 years) includ-
ed in the survey in Cameroon where the prevalence of mild MSI was particularly high. The assess-
ment of mild MSI deserves further attention in future studies using this method. Concerning causes 
of MSI, our findings support those in Rwanda where a non-traumatic non-infective cause was the 
most common diagnostic category and the most common individual diagnosis was joint problems 
(13% of MSI diagnoses).  
The Global Burden of Disease Study estimates that in 2015 the most important contributors to global 
years lived with disability were musculoskeletal disorders (18.5% [16.4 – 20.9%]) (14). Lower back 
and neck pain were estimated in 2013 as the leading cause of years lived with disability in Cameroon 
(15). There are few other data in the region with which to compare our findings. Population preva-
lence of all disability was estimated as 6.2% (95% CI 5.2-7.2%) (16) through self-report in the North 
West Region of Cameroon. Cameroon’s Demographic and Health and Multiple Indicator Survey 
(2011) estimated that 5.4% of the population in Cameroon lives with a disability, with 6.6% in the 
North-West Region (17). However, it is not clear what proportion of these estimates were physical 
disability. More comparable data from studies employing the same sampling methods and case defi-
nition are needed in different settings to strengthen the evidence on epidemiology of MSI in LMIC 
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settings (6). 
Our study highlights the high prevalence of MSI among older people. This finding supports stud-
ies of older person’s health in Botswana and Malawi that demonstrate increased probability of mus-
culoskeletal disease (18) and functional limitations (19) respectively. As the prevalence of musculo-
skeletal disorders increases with age, it follows that there will be a marked increase in requirements 
for health care and community support in the coming years. Despite having great need for rehabili-
tation services than younger age groups, evidence suggests that older people in sub-Saharan Africa 
use these services less frequently (20). Access to health and other services (for all ages) may be en-
couraged through community-based rehabilitation (CBR) programmes in rural communities. In addi-
tion, the development of programmes that serve populations at the district level (21), where needs 
can be assessed and resources identified, may improve access to preventative services and rehabili-
tation.  
Medical or rehabilitation services were recommended for the majority of the people identified 
as having an MSI in this survey, 38% of people with MSI had not previously received any such ser-
vices. These data demonstrate a large treatment gap for MSI in Cameroon, similar to that of Rwanda 
(10). The challenge of improving access both to preventative and rehabilitation services is experi-
enced globally (22-25). As the burden of MSI is predicted to increase as populations age, there is a 
need to recognise musculoskeletal conditions as a global public health priority. Innovative ways to 
fill this health service gap are required. For example, the use of mobile tools for the delivery of a 
home exercise programme in low resource settings (26) warrants further investigation. 
The extent of overlap between the populations identified by clinical assessment and self-report 
varied considerably according to the severity of self-reported difficulties. The broader category of 
‘some or more difficulty’ identified many people who did not have a moderate/severe clinical MSI; 
however sensitivity and specificity were within acceptable range with the inclusion of mild MSI. Us-
ing the narrower category ‘a lot of difficulty’ missed a considerable number of clinically confirmed 
cases.  These two measurement approaches capture different aspects of disability (8) and a recent 
analysis has suggested that, where resources permit, using the two measures together in disability 
surveys may be helpful to identify the majority of people with disability (8). The need for RAM is 
highlighted as the self-reported measures alone at the level of ‘some or more difficulty’ underesti-
mate MSI and do not provide information on clinical need.  
This was an all-age population based survey that used a standardised examination protocol 
to provide estimates of musculoskeletal impairment, with assessment by physiotherapists. Compact 
segment sampling reduced the likelihood of selection bias (27) and facilitated call back at house-
holds where people were unavailable. There were also study limitations. The study relied on simpli-
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fied examination procedures that could be conducted in the field. Diagnostic tools were limited to 
history and clinical examination, which restricted the identification of aetiologies reliant on complex 
investigations. For example, we did not use the neutral-zero-method with joint conditions because 
the method requires a goniometer and expertise to measure the precise available range of motion. 
This study provides an overview of the treatment needs, but details on specific recommendations 
(such as classification of medication recommended) were not collected and deserve further atten-
tion in future research. 
 
Conclusions 
This paper contributes data to the epidemiology of MSI globally and provides useful information on 
planning services for persons with MSI in Cameroon. 
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